Bank of New York Mellon’s Syneron Medical Ltd ELOS Stock Holding History

Bank of New York Mellon’s Portfolio ELOS Stock Details ELOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-24,563	Closed	-$304K	–	4363
2015 Q1	$304K	Sell	24,563 -61,340	-71%	-$679K	﹤0.01%	3770
2014 Q4	$801K	Buy	85,903 +10,233	+14%	+$98.7K	﹤0.01%	3422
2014 Q3	$758K	Sell	75,670 -23,250	-24%	-$237K	﹤0.01%	3451
2014 Q2	$1.02M	Hold	98,920	–	–	﹤0.01%	3293
2014 Q1	$1.23M	Buy	98,920 +14,490	+17%	+$172K	﹤0.01%	3178
2013 Q4	$1.04M	Sell	84,430 -9,323	-10%	-$96.9K	﹤0.01%	3286
2013 Q3	$809K	Buy	93,753 +17,433	+23%	+$150K	﹤0.01%	3352
2013 Q2	$664K	Buy	+76,320	New	+$682K	﹤0.01%	3388

Other funds holding ELOS

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Bank of New York Mellon's ELOS Position: Q2 2015 in Review

Bank of New York Mellon sold out of Syneron Medical Ltd (ELOS) in Q2 2015, closing a stake of 24,563 shares — an estimated $304K sold.

Bank of New York Mellon first reported a position in ELOS in Q2 2013 and held it in 8 quarters. The position peaked at $1.23M in Q1 2014. 79 funds tracked by Wall St. Rank hold ELOS as of Q2 2015.

Bank of New York Mellon reported no remaining Syneron Medical Ltd position as of Q2 2015 after selling out during the quarter.
Bank of New York Mellon sold 24,563 Syneron Medical Ltd shares in Q2 2015, an estimated $304K.
Bank of New York Mellon first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 8 quarters.
Bank of New York Mellon's Syneron Medical Ltd position peaked at $1.23M in Q1 2014.
79 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2015.

Based on Bank of New York Mellon's 13F filing for Q2 2015, filed 6 Aug 2015.